Michael Frazis
Frazis Capital Podcast
Michael Frazis and Ellianna discuss the life sciences, technology, and their latest investment ideas.
Author
Michael Frazis
Category
Podcast website
Latest episode
Jul 6, 2026
Where to listen?
Podcasts in the app Replaio Radio Coming soonPodcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts
Episodes
Episode 21: A high-tech company with explosive growth...and various other science things you don't want to miss 12.02.2020 45:59
Matthew Shribman has accumulated over 25 million views across platforms for his 'Science in the Bath' series, available here: https://www.youtube.com/channel/UCoSRNBi6F4jN0CYq-sRcOHQ We talk about how birds literally 'see' the Earth's magnetic field, and cover Twist Bioscience, a company that's revolutionizing gene synthesis. Twist is working on DNA as a viable storage medium for compu...
Episode 20: Australian bushfires, and two Aussie companies revolutionising burns treatment 05.02.2020 32:29
Peter Stevens joins us to discuss Coronavirus and two Aussie burns innovators: Avita and Polynovo. Find more information about us here: www.fraziscapitalpartners.com And please get in touch if you have questions you'd like us to answer on the podcast, suggestions or feedback. If you'd like to know more about us see: www.fraziscapitalpartners.com 00:28 – Coronavirus, and how to calculat...
Episode 19: How we’re different 04.02.2020 28:01
Peter Stevens rejoins us to discuss investment strategy and our top new picks. If you'd like to know more about us see: www.fraziscapitalpartners.com 1:00 – Recap of 2019; how shorts hampered performance and the stocks that went well 3:58 – Why doing less is a key lesson 5:58 – Where Frazis Capital sits in portfolios 8:06 – How companies like Xero and Afterpay shot the lights out and how inv...
Episode 18: Portfolio updates and new ideas with Peter Stevens 20.12.2019 42:24
Peter Stevens joins us to talk about some of our long held investments and latest new ideas. Peter Stevens has rejoined Frazis Capital Partners, and writes his own market blog here: https://insufficientcapital.com/ If you'd like to know more about us see: www.fraziscapitalpartners.com
Episode 17: Strategy, biotech and growth investing with Eti Amegor 29.11.2019 1:12:04
A wide-ranging conversation with Eti Amegor, of Axius Partners. We discuss growth investing, Carvana and our top biotech picks, including a drug to reduce stress. Eti runs a podcast himself and asked some tough questions! This one was a lot of fun. Eti's podcast 'Suits and Kicks' is available here: https://podcasts.apple.com/au/podcast/suits-and-kicks/id1454889632 If you'd...
Episode 16: Paul Brennan goes deep on the Australian economy 08.11.2019 50:25
Paul Brennan is a markets veteran with over 20 years at Citigroup in Australia, most recently as Chief Economist. He now consults for a wide range of clients, and in his spare time, offers his expertise to university students. It's always great to have a chat with someone who measures their market experience in decades, so this was a real privilege. We go deep on economics, the Austral...
Episode 15: Growth opportunities and the software sell-off with Peter Stevens 29.10.2019 43:46
Peter Stevens joins us to talk about the recent growth sell off and the new opportunities and investment ideas we're looking at. If you'd like to know more about us see: www.fraziscapitalpartners.com
Episode 14: Value is Dead, Long Live Value with Mario Emmanuel 11.10.2019 42:37
There are many ways to create value without showing after-tax profits. Michael Frazis and Mario Emmanuel discuss new approaches. https://www.fraziscapitalpartners.com/post/value-is-dead-long-live-value
Episode 13: A chat with Anna Satouris about energy, markets and prices 23.09.2019 16:27
Recorded 16 September, 2019, this podcast features Anna Satouris and a discussion around energy, markets and prices.
Episode 12: We discuss a strong reporting season and our fee rebate to long term clients 30.08.2019 24:53
Michael Frazis and Anna Satouris discuss Carvana, Afterpay, Pinduoduo and our recent fee rebate to long term clients.
Episode 11: Rebecca Gingell on alloy design and OxMet, an Oxford University spinout 18.07.2019 46:27
This episode features a chat with Rebecca Gingell, who runs business development at OxMet Technologies, an Oxford University spin-out utilizing decades of academic modelling expertise to design and commercialize new alloys. It turns out that almost every alloy we use in every day life was discovered long ago. Rebecca explains how we've barely scratched the surface of the potential numb...
Episode 10: Computing with live neurons - Clinicloud founder takes us through his latest venture 28.05.2019 59:59
In this episode we recorded a fascinating chat with Hon Weng Chong, the founder CC Labs . Hon Wen first rose to fame as a cofounder of Clinicloud , an innovative medical devices company that won FDA approval. The firm was originally backed by Tencent and Ping An, and is now developing a new form of computing: instead of using silicon chips, they are growing live self-organising networks of neurons...
Episode 9: We go deep with Eti Amegor on innovation, disruption and the role of hedge funds in a portfolio 18.05.2019 35:16
In this episode we have a chat with Eti Amegor, director of Axius Partners and founder of Suits and Kicks ( http://www.suitsandkicks.com/ ). At Axius, Eti advises and raises capital for some of the most distinguished and highest returning investment funds in the world. We discuss innovation and disruption in technology, and the role of hedge funds in a portfolio.
Episode 8: A conversation with Anna Satouris on Disney's new streaming service and portfolio protection 12.05.2019 19:45
We discuss the market outlook, Disney's new streaming service and portfolio protection.
Episode 7: Michael Wayne and Michael Frazis discuss Medallion, markets, Alzheimers and biotech 01.04.2019 23:39
Michael Wayne is the founder of the Medallion Financial Group, a wealth management firm specialising in investment advice. Michael discusses his firm, some investment ideas, and the outlook for financial markets, as well as Biogen's latest Alzheimer's trial failure in biotech land. More information on Medallion and Michael Wayne can be found here: https://www.medallionfinancial.com.au...
Episode 6: Google, Carvana and IPG Photonics, a discussion with Harvey Migotti 18.03.2019 38:16
Michael Frazis and Harvey Migotti discuss Google, IPG Photonics and Carvana. Harvey has a background in both public and private market investing, with roles at Balyasny, Amiya and Apax. https://www.fraziscapitalpartners.com/
Episode 5: Mike and Mario discuss some new investment ideas 05.03.2019 21:03
State of technology, famous investors, and some ways to hedge against turbulent times.
Episode 4: Mike and Eti Amegor discuss volatility, real estate and how local investors are currently allocating 19.02.2019 42:46
Michael Frazis and Eti Amegor go deep into volatility, why the beginning and end of 2018 were so different, and where Australian investors are putting their money. Eti also talks about his blog Suits and Kicks, for high achieving professionals who want to perform at the highest level both inside and outside the office. Available here: http://www.suitsandkicks.com/
Episode 3: Fiat, value, and the Aussie dollar 15.02.2019 20:50
Michael and Mario discuss Fiat, cyclicals, value, and Aussie fundamentals.
Episode 2: Afterpay, Cooper Energy, Stanmore Coal and the Australian Housing Market 13.02.2019 20:46
Michael Frazis and Anna Satouris discuss Afterpay, Cooper Energy, Stanmore Coal and the Australian housing market.
Episode 1: Rundown of 2018 and a review of some of our US tech investments 31.01.2019 36:17
Michael Frazis and Mario Emmanuel discuss financial markets in 2018, the current outlook, and some of our latest investments.
Similar podcasts
Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.